Nils Wilking (Former)
1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The Porto European Cancer Research Summit 2021
(
- Contribution to journal › Article
- 2017
-
Mark
Assessment of value for resource allocation in cancer care
(
- Contribution to journal › Article
-
Mark
Societal challenges of precision medicine : Bringing order to chaos
(
- Contribution to journal › Article
- 2015
-
Mark
Insights into cancer surveillance in Central and Eastern Europe, Israel and Turkey
(
- Contribution to journal › Article
- 2014
-
Mark
Audio-recorded information to patients considering participation in cancer clinical trials - a randomized study
(
- Contribution to journal › Article
-
Mark
A Catalyst for Change: The European Cancer Patient's Bill of Rights.
2014) In The Oncologist(
- Contribution to journal › Article
- 2013
-
Mark
Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxel
(
- Contribution to journal › Article
- 2000
-
Mark
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer : a randomised trial
(
- Contribution to journal › Article
- 1998
-
Mark
Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401
1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(4). p.403-411(
- Contribution to journal › Article
- 1994
-
Mark
Metabolism of estrone sulfate by normal breast tissue : Influence of menopausal status and oral contraceptives
(
- Contribution to journal › Article